A phase I/II study of ruxolitinib with frontline neoadjuvant and post-surgical therapy in patients with advanced epithelial ovarian, Fallopian tube, or primary peritoneal cancer.

被引：0

作者：

Landen, Charles N.

Buckanovich, Ronald J.

Sill, Michael

Mannel, Robert S.

Walker, Joan L.

Disilvestro, Paul

Mathews, Cara Amanda

Mutch, David Gardner

Hernandez, Marcia

Martin, Lainie P.

Bishop, Erin

Gill, Sarah

Gordinier, Mary E.

Burger, Robert Allen

Aghajanian, Carol

Liu, Joyce F.

Moore, Kathleen N.

Bookman, Michael A.

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[2] UPMC Hillman Canc Ctr, Pittsburgh, PA USA

[3] Gynecol Oncol Grp Stat & Data Ctr, Buffalo, NY USA

[4] Stephenson Canc Ctr, Oklahoma City, OK USA

[5] Univ Oklahoma Hlth Sci Ctr, Oklahoma City, OK USA

[6] Women Infants Hosp, Providence, RI USA

[7] Brown Univ, Women & Infants Hosp, Dept Obstet & Gynecol, Program Womens Oncol, Providence, RI USA

[8] Washington Univ St Louis, Sch Med, St Louis, MO USA

[9] Mercy Hosp Springfield, Springfield, MO USA

[10] Univ Pennsylvania, Abramson Canc Ctr, Philadelphia, PA USA

[11] Froedtert & Med Coll Wisconsin, Milwaukee, WI USA

[12] Nancy N & JC Lewis Canc & Res Pavil, Savannah, GA USA

[13] Louisville Oncol, Louisville, KY USA

[14] Univ Pennsylvania, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA USA

[15] Mem Sloan Kettering Canc Ctr, New York, NY USA

[16] Dana Farber Canc Inst, Boston, MA USA

[17] Univ Oklahoma Hlth Sci Ctr, Div Obstet & Gynecol, Dept Gynecol Oncol, Stephenson Canc Ctr, Oklahoma City, OK USA

[18] Univ Arizona, Tucson, AZ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期

基金：

美国国家卫生研究院;

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5501

引用

页数：1